🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
313,52 USD
Máx. histórico
322,75
4 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-2,86%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,12%
Cierre anterior
307,02
Rango de hoy
309,46 – 317,76
Volumen hoy
195.564
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 33,04 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 350,92 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 23 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 18/06/2021 | 78,79 | 79,76 | 77,04 | 78,98 | -0,93% | 3,45% | 528.349 |
| 17/06/2021 | 77,70 | 80,95 | 77,39 | 79,73 | +2,08% | 4,58% | 239.488 |
| 16/06/2021 | 76,79 | 78,23 | 76,33 | 78,10 | +1,11% | 2,48% | 186.910 |
| 15/06/2021 | 77,27 | 77,83 | 76,19 | 77,24 | +0,62% | 2,12% | 242.053 |
| 14/06/2021 | 77,31 | 78,38 | 74,89 | 76,77 | -0,46% | 4,51% | 350.416 |
| 11/06/2021 | 75,79 | 77,30 | 74,92 | 77,12 | +2,32% | 3,14% | 179.857 |
| 10/06/2021 | 75,00 | 75,84 | 74,32 | 75,38 | +1,16% | 2,03% | 240.931 |
| 09/06/2021 | 74,88 | 75,17 | 73,30 | 74,52 | +0,78% | 2,49% | 185.627 |
| 08/06/2021 | 75,15 | 76,10 | 72,64 | 73,94 | -0,83% | 4,61% | 259.686 |
| 07/06/2021 | 72,53 | 74,85 | 71,94 | 74,56 | +3,58% | 4,01% | 293.349 |
| 04/06/2021 | 71,12 | 72,36 | 69,36 | 71,98 | +2,09% | 4,22% | 227.947 |
| 03/06/2021 | 70,03 | 71,47 | 68,78 | 70,51 | -0,28% | 3,84% | 213.039 |
| 02/06/2021 | 71,43 | 72,41 | 69,48 | 70,71 | -0,19% | 4,10% | 404.277 |
| 01/06/2021 | 73,59 | 73,59 | 70,63 | 70,85 | -3,51% | 4,02% | 218.008 |
| 28/05/2021 | 73,56 | 74,82 | 73,13 | 73,42 | +0,18% | 2,30% | 197.169 |
| 27/05/2021 | 72,37 | 74,24 | 71,77 | 73,29 | +2,25% | 3,40% | 351.859 |
| 26/05/2021 | 74,73 | 75,00 | 70,33 | 71,68 | -3,90% | 6,24% | 332.142 |
| 25/05/2021 | 76,08 | 77,07 | 74,56 | 74,59 | -1,69% | 3,30% | 209.512 |
| 24/05/2021 | 77,29 | 77,29 | 75,55 | 75,86 | -0,72% | 2,26% | 144.430 |
| 21/05/2021 | 77,82 | 78,24 | 75,71 | 76,41 | -0,86% | 3,25% | 201.337 |
| 20/05/2021 | 74,92 | 77,16 | 74,51 | 77,07 | +2,97% | 3,54% | 218.008 |
| 19/05/2021 | 75,67 | 76,59 | 74,34 | 74,85 | -2,07% | 2,98% | 240.129 |
| 18/05/2021 | 78,67 | 79,54 | 76,38 | 76,44 | -2,11% | 4,02% | 275.716 |
| 17/05/2021 | 80,16 | 81,50 | 77,66 | 78,08 | -3,36% | 4,79% | 206.947 |
| 14/05/2021 | 77,94 | 81,02 | 76,74 | 80,80 | +4,55% | 5,50% | 210.474 |
| 13/05/2021 | 78,14 | 79,69 | 76,29 | 77,28 | -1,17% | 4,35% | 239.649 |
| 12/05/2021 | 80,82 | 80,92 | 78,11 | 78,20 | -3,97% | 3,47% | 221.695 |
| 11/05/2021 | 76,62 | 81,77 | 74,97 | 81,43 | +3,06% | 8,88% | 262.732 |
| 10/05/2021 | 80,90 | 80,90 | 78,42 | 79,01 | -3,03% | 3,06% | 241.572 |
| 07/05/2021 | 79,81 | 82,07 | 79,29 | 81,48 | +3,27% | 3,49% | 238.206 |